On Tuesday, Elevance Health Inc (NYSE: ELV) opened lower -1.38% from the last session, before settling in for the closing price of $407.60. Price fluctuations for ELV have ranged from $391.02 to $567.26 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 13.24% over the last five years. Company’s average yearly earnings per share was noted 0.14% at the time writing. With a float of $231.44 million, this company’s outstanding shares have now reached $233.07 million.
The firm has a total of 104900 workers. Let’s measure their productivity. In terms of profitability, gross margin is 27.94%, operating margin of 5.29%, and the pretax margin is 4.77%.
Elevance Health Inc (ELV) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Healthcare Plans industry is another important factor to consider. The insider ownership of Elevance Health Inc is 0.21%, while institutional ownership is 90.32%. The most recent insider transaction that took place on Oct 18 ’24, was worth 3,205,182. In this transaction EVP & President, Commercial of this company sold 7,417 shares at a rate of $432.14, taking the stock ownership to the 8,423 shares. Before that another transaction happened on Oct 18 ’24, when Company’s Director proposed sale 7,417 for $432.28, making the entire transaction worth $3,206,221.
Elevance Health Inc (ELV) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted 5.62 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 5.59) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 10.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.01% during the next five years compared to 12.18% growth over the previous five years of trading.
Elevance Health Inc (NYSE: ELV) Trading Performance Indicators
Check out the current performance indicators for Elevance Health Inc (ELV). In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.54. Likewise, its price to free cash flow for the trailing twelve months is 107.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 27.43, a number that is poised to hit 3.99 in the next quarter and is forecasted to reach 34.98 in one year’s time.
Technical Analysis of Elevance Health Inc (ELV)
Analysing the last 5-days average volume posted by the [Elevance Health Inc, ELV], we can find that recorded value of 1.81 million was better than the volume posted last year of 1.18 million. As of the previous 9 days, the stock’s Stochastic %D was 49.21%. Additionally, its Average True Range was 10.23.
During the past 100 days, Elevance Health Inc’s (ELV) raw stochastic average was set at 6.21%, which indicates a significant decrease from 25.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 19.51% in the past 14 days, which was lower than the 29.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $454.92, while its 200-day Moving Average is $508.81. Now, the first resistance to watch is $407.80. This is followed by the second major resistance level at $413.65. The third major resistance level sits at $418.54. If the price goes on to break the first support level at $397.07, it is likely to go to the next support level at $392.18. Now, if the price goes above the second support level, the third support stands at $386.33.
Elevance Health Inc (NYSE: ELV) Key Stats
There are currently 231,923K shares outstanding in the company with a market cap of 93.22 billion. Presently, the company’s annual sales total 171,340 M according to its annual income of 5,987 M. Last quarter, the company’s sales amounted to 45,106 M and its income totaled 1,016 M.
